The search for the best HCC coding software has never been more consequential, and the answer has never been less obvious. Ask ten Medicare Advantage plan leaders which platform they’re using and why, and you’ll hear the same few vendor names repeated with confidence but rarely with a clear rationale. Most evaluations are built around demos, price negotiations, and references from peer plans using the same software. In 2025, that was a reasonable process. In CY 2027, it is not enough.
CMS has fundamentally changed what a compliant HCC coding workflow must look like. Diagnoses from unlinked chart review records and diagnoses from audio-only telehealth encounters will be excluded from risk score calculation starting with the CY 2027 Midyear model run. RADV audits now reach all eligible contracts annually, with sample sizes up to 200 records per plan. Every diagnosis submitted must be traceable to a face-to-face or audio-video encounter, documented with MEAT criteria, signed, and dated within the payment year.
These changes do not just raise the bar for documentation. They change the definition of what the best HCC coding software has to do to remain a compliant, defensible tool. This guide gives MA plan leaders and their teams the evaluation framework to assess any platform against the actual requirements for 2027, not against the sales deck.
Before 2027, the dominant model for HCC coding software was retrospective: trained coders reviewed charts after encounters closed, surfaced HCC suspects, and submitted diagnoses back through the plan’s risk adjustment pipeline. The best tools in that model were the ones that could process the most charts at the lowest cost with the highest acceptance rates.
That model still exists. But CMS has now drawn a line around where diagnoses can come from and still count toward risk scores. An unlinked chart review record, meaning a retrospective review submitted without a corresponding, qualifying encounter, is excluded. A diagnosis surfaced from a phone-only telehealth encounter billed with modifier “93” or “FQ” is excluded. These are not edge cases; they describe a substantial share of the diagnoses that retrospective-only platforms have traditionally produced.
The best HCC coding software for CY 2027 is software built around the encounter, not built to work around it. Plans evaluating vendors in this environment need to ask different questions than they asked three years ago.
This is the foundational question, and it separates two fundamentally different categories of tools.
Point-of-care software works prospectively: it surfaces suspected HCC diagnoses, care gaps, and documentation opportunities before or during the clinical encounter, while the provider is still with the patient and the documentation can be addressed at the source. Retrospective software works after the encounter, reviewing completed charts and submitting diagnoses back through the pipeline.
Prospective risk adjustment reduces retrospective burden by 30 to 50 percent by capturing diagnoses during visits rather than recovering them afterward. More importantly in the CY 2027 environment, prospective capture produces encounter-linked diagnoses by design: the code is documented at the face-to-face visit, during the encounter, by the treating provider. That is the documentation standard CMS is now enforcing.
Plans that rely primarily on retrospective chart review are not getting the wrong tool; they are getting a tool that produces diagnoses CMS may not count. The best HCC coding software does not eliminate retrospective review, but it makes the encounter the primary capture point, not the exception.
Inferscience’s HCC Assistant is built on this principle: AI-driven suspect identification delivered before the visit, with coder-curated alerts surfaced during the encounter in the provider’s existing workflow, generating diagnoses that are encounter-linked from the moment they are documented.
The MAO-004 report will show plans which diagnoses CMS disallowed and why, including the new Reason Code “U” for unlinked CRR diagnoses and the existing Reason Code “H” for audio-only exclusions. But that report comes after submission. Plans that learn about their exclusion exposure from the MAO-004 are already managing a problem rather than preventing one.
The best HCC coding software flags exclusion-risk diagnoses in the submission pipeline before they go to CMS. That means identifying diagnoses sourced from encounters with modifier “93” or “FQ” on all CPT lines (audio-only), and identifying diagnoses sourced from chart review records without a qualifying linked encounter (unlinked CRR). Both of these are detectable at the point of submission if the software is built to look.
Ask any vendor: does your platform flag audio-only encounter diagnoses before submission? Does it identify unlinked CRR submissions and apply the parent organization switcher exception logic? If the answer is no, or if the answer is that the MAO-004 serves that function, the tool is designed for cleanup, not prevention.
HCC Validator from Inferscience is built specifically for this layer: pre-submission diagnosis validation that catches exclusion-risk codes before they enter the pipeline, so the MAO-004 confirms what was expected rather than revealing what went wrong.
MEAT documentation, which requires that each HCC-supporting diagnosis be Monitored, Evaluated, Assessed, and Treated in the clinical record, is not new. What is new is the audit environment that tests whether plans can prove it.
CMS now audits all eligible MA contracts annually, with samples ranging from 35 to 200 records per plan and a five-month submission window. PY 2020 audits began in February 2026. Plans that validate documentation before submission consistently reduce RADV exposure by 60 to 80 percent compared to plans that retrieve charts reactively after receiving a notice. Records that are unsigned, illegible, or lack clinical specificity will fail regardless of how accurate the coding is.
The best HCC coding software does not just check whether an HCC code exists; it checks whether the underlying documentation supports the code under RADV review standards. That means validating that the encounter is dated within the payment year, that the provider type qualifies, that the diagnosis is documented with clinical specificity, and that MEAT criteria are present in the note.
Ask any vendor: does your platform surface MEAT documentation gaps before the encounter closes, or only after chart review? Does it identify records that would fail a RADV audit based on documentation quality, not just code presence? Preparing for RADV audits with documentation quality controls at the point of care is the posture that holds up when the audit notice arrives.
EHR integration is a prerequisite for effective risk adjustment in 2026 and beyond, not a premium feature. Software that requires coders or providers to log into a separate platform, upload charts manually, or review suspects outside the clinical workflow creates friction that limits adoption and reduces capture rates. The best HCC coding software lives inside the system providers already use.
This matters beyond convenience. A point-of-care tool that requires the provider to navigate away from the EHR during the encounter will not be used consistently. Inconsistent use produces inconsistent capture. Inconsistent capture produces documentation gaps. Documentation gaps produce RADV failures.
Evaluate any platform for how it surfaces information to the clinician: is it embedded in the EHR workflow, or adjacent to it? Does it require the provider to take an action in a separate system, or does it deliver suspects and care gap alerts within the encounter documentation flow? Can coders complete their review without leaving the EHR?
Inferscience’s AI Chart Assistant assists providers before, during, and after the visit with chart summaries, a query-enabled chatbot, and easily accessible data, reducing the cognitive load at the point of care and supporting the documentation quality that HCC capture requires. The encounter results in better care for the patient and better results and documentation for the provider.
Two-way coding, which means identifying both diagnoses to add and diagnoses to remove from risk adjustment submissions, is now the defensible standard. Add-only retrospective programs, where coders surface new codes without auditing existing submissions for overcoding or unsupported diagnoses, face active DOJ enforcement and carry significant compliance risk.
The best HCC coding software supports both directions. It finds diagnoses that are clinically supported and missing from the submission. It also flags diagnoses that are present in the submission but not supported by the clinical record, whether because documentation has lapsed, a condition has resolved, or a code was carried forward without current-year clinical evidence.
Plans that use add-only tools are managing one half of the compliance picture. Ask any vendor: does your platform identify diagnoses in the current submission that lack current-year documentation support? If the answer is no, the tool is optimizing revenue without optimizing compliance, and those are not the same objective in 2027.
After the foundational criteria are met, the best platforms differentiate on what they make easy rather than merely possible. A few capabilities separate category leaders from the field.
Pre-visit coder workflow, not just pre-visit alerts, is one. The best tools surface suspect diagnoses and supporting evidence to coders before the encounter, so a curated, clinician-ready summary is waiting in the EHR when the provider opens the chart. This is different from alerting the provider in the moment: it gets the coder’s judgment into the workflow before the clinical encounter, not alongside it.
Care gap integration is another. Plans that close HCC coding gaps and Stars care gaps in the same encounter get more value from each clinical touchpoint. Inferscience’s Quality Assistant surfaces quality measure gaps alongside HCC suspects, so the encounter addresses both risk adjustment and Stars performance without adding a second workflow layer.
Finally, the best platforms make their reasoning legible. An AI-generated HCC suspect is only as useful as a provider’s willingness to act on it. Platforms that surface a code without the clinical rationale behind it create uncertainty that leads to dismissal. The best HCC coding software shows the provider why the suspect was flagged, what evidence in the chart supports it, and what documentation would confirm it.
A vendor’s feature list describes what the software can do. Their compliance posture describes what they will help you do when CMS changes the rules, which it will again after CY 2027.
Ask vendors specifically: how did your platform adapt to the CY 2027 unlinked CRR exclusion? What changes did you make to flag audio-only encounter diagnoses? How do you handle the November 2026 MAO-004 reissue and the new Reason Code “U”? How quickly will your platform reflect the Python-only model software transition that begins with CY 2028 Initial?
Vendors who can answer these questions specifically are building compliance into the product, not responding to it after the fact. Vendors who cannot are selling you a platform that was current as of the last update, with no guarantee of what “current” means for the next rule change.
The regulatory environment for Medicare Advantage risk adjustment will not become simpler. The best HCC coding software is the one that keeps pace with it, and the best vendor is one that proves it has been keeping pace already.
What is the best HCC coding software for Medicare Advantage plans? The best HCC coding software for CY 2027 is software that captures diagnoses at the point of care through EHR-integrated workflows, validates documentation against MEAT criteria before submission, and excludes diagnoses from audio-only telehealth encounters and unlinked chart review records that CMS will not count toward risk scores. Plans should evaluate any platform against these criteria before the CY 2027 Midyear model run, which applies both exclusions retroactively to January 2027 payments.
How do the CY 2027 diagnosis exclusion rules affect HCC coding software? CMS will exclude diagnoses from two sources starting with the CY 2027 Midyear model run: unlinked chart review records and audio-only telehealth encounters billed with modifier “93” or “FQ.” Software that relies primarily on retrospective chart review to generate diagnoses may produce submissions that CMS will not accept for risk score calculation. The best HCC coding software identifies these exclusion-risk diagnoses before submission, not after the MAO-004 report reveals them.
What is the difference between prospective and retrospective HCC coding software? Prospective HCC coding software surfaces diagnosis suspects and documentation gaps before or during the clinical encounter, capturing codes at the point of care with encounter-linked documentation. Retrospective HCC coding software reviews completed charts after encounters close and submits diagnoses back through the pipeline. CY 2027 regulations make encounter-linked documentation the compliance standard, which makes prospective capture the defensible primary workflow and retrospective review a validation layer rather than the primary source of HCC diagnoses.
What does MEAT documentation mean in the context of HCC coding software? MEAT stands for Monitor, Evaluate, Assess, and Treat. For a diagnosis to qualify for risk adjustment, the clinical record must contain documentation that the treating provider is actively managing the condition in one of these four ways. The best HCC coding software validates MEAT documentation quality at the point of capture, not just code presence, so that diagnoses are defensible under RADV audit standards before they are submitted.
What questions should MA plans ask when evaluating HCC coding software? Plans should ask: Does the software work prospectively at the point of care, or only retrospectively after the encounter? Does it flag audio-only and unlinked CRR diagnoses before submission? Does it validate MEAT documentation quality, not just code presence? Does it integrate directly with your EHR? Does it support two-way coding to identify both missing and unsupported diagnoses? And how has the vendor updated the platform in response to CY 2027 regulatory changes?
The best HCC coding software for CY 2027 is not the platform with the longest vendor history or the largest client roster. It is the platform that builds the encounter into every step of the workflow, validates documentation before it reaches CMS, and has already adapted to the regulatory changes that are now determining what gets counted and what gets excluded.
Plans that make this evaluation with precision now, against the actual CY 2027 requirements, will enter the Midyear model run with a compliant submission posture, a defensible RADV position, and risk scores that reflect what was documented rather than what was disallowed.
Contact Inferscience to see how HCC Assistant and HCC Validator are built to meet the CY 2027 standard, and request a walkthrough of what pre-submission exclusion detection and point-of-care HCC capture look like in practice.
